Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asim Amin

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|June 25, 2008
No association of miscarriage and BRCA carrier status in Pakistani breast/ovarian cancer patients with a history of parental consanguinityMuhammad U Rashid, Diana Torres, Farah Rasheed, et al.
Breast Cancer Research and Treatment|November 29, 2007
No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriersMuhammad U Rashid, Diana Torres, Anbreen Zaidi, et al.
Southern Medical Journal|March 5, 2019
Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated ColitisJ Daniel Herlihy, Stephen Beasley, Andrew Simmelink, et al.
BMC Cancer|August 25, 2016
High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patientsMuhammad Usman Rashid, Noor Muhammad, Seerat Bajwa, et al.
Cancer Immunology, Immunotherapy : CII|September 11, 2014
Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcomeDavid M Foureau, Asim Amin, Richard L White, et al.
Hereditary Cancer in Clinical Practice|September 19, 2019
Spectrum and prevalence of <i>BRCA1/2</i> germline mutations in Pakistani breast cancer patients: results from a large comprehensive studyMuhammad Usman Rashid, Noor Muhammad, Humaira Naeemi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trialJohn A Thompson, Omid Hamid, David Minor, et al.
Cancer|October 29, 2019
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case seriesKourtney Holbrook, Jose Lutzky, Michael A Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanomaJeffrey Weber, John A Thompson, Omid Hamid, et al.
Cancer Immunity|July 9, 2013
Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanomaJeffrey Weber, Omid Hamid, Asim Amin, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|June 25, 2008
No association of miscarriage and BRCA carrier status in Pakistani breast/ovarian cancer patients with a history of parental consanguinityMuhammad U Rashid, Diana Torres, Farah Rasheed, et al.
Breast Cancer Research and Treatment|November 29, 2007
No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriersMuhammad U Rashid, Diana Torres, Anbreen Zaidi, et al.
Southern Medical Journal|March 5, 2019
Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated ColitisJ Daniel Herlihy, Stephen Beasley, Andrew Simmelink, et al.
BMC Cancer|August 25, 2016
High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patientsMuhammad Usman Rashid, Noor Muhammad, Seerat Bajwa, et al.
Cancer Immunology, Immunotherapy : CII|September 11, 2014
Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcomeDavid M Foureau, Asim Amin, Richard L White, et al.
Hereditary Cancer in Clinical Practice|September 19, 2019
Spectrum and prevalence of <i>BRCA1/2</i> germline mutations in Pakistani breast cancer patients: results from a large comprehensive studyMuhammad Usman Rashid, Noor Muhammad, Humaira Naeemi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trialJohn A Thompson, Omid Hamid, David Minor, et al.
Cancer|October 29, 2019
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case seriesKourtney Holbrook, Jose Lutzky, Michael A Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanomaJeffrey Weber, John A Thompson, Omid Hamid, et al.
Cancer Immunity|July 9, 2013
Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanomaJeffrey Weber, Omid Hamid, Asim Amin, et al.
Pageof 6